Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need.
Company overview
PROSTVAC™ Prostate cancer vaccine
IMVAMUNE® Smallpox vaccine
All projects
Immunotherapy offers improved treatment options with better quality of life
Prostate cancer Breast cancer
Development of preventative countermeasures against biological weapons
Smallpox Anthrax
Early stage projects in various infectious diseases
HIV Measles/RSV
17 November 2010 Medicare Panel Backs Prostate Drug
26 August 2010 Senators Ask Why Medicare Is Reviewing Provenge